Cancer Biomarkers Market By Biomarker Type (Genetic Biomarkers, Protein Biomarkers, Metabolic Biomarkers, Epigenetic Biomarkers), By Cancer Type (Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Melanoma, Blood Cancers, Others), By Technology (Omics Technologies, Imaging Technologies, Bioinformatics, Immunoassays, Next-Generation Sequencing, PCR-based Techniques), By Application (Diagnostics, Prognostics, Risk Assessment, Therapy Prediction/Monitoring, Companion Diagnostics), By End-user (Hospitals, Cancer Research Institutes, Diagnostic Laboratories, Biopharmaceutical and Biotechnology Companies, Others), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 – 2035
Published Date: Jun 2025 | Report ID: MI2975 | 215 Pages
Report Coverage:
By Biomarker Type
- Genetic Biomarkers
- Protein Biomarkers
- Metabolic Biomarkers
- Epigenetic Biomarkers
By Cancer Type
- Breast Cancer
- Lung Cancer
- Colorectal Cancer
- Prostate Cancer
- Melanoma
- Blood Cancer
- Others
By Technology
- Omics Technologies
- Imaging Technologies
- Bioinformatics
- Immunoassays
- Next-Generation Sequencing
- PCR-based Techniques
By Application
- Diagnostics
- Prognostics
- Risk Assessment
- Therapy Monitoring
- Companion Diagnostics
- Others
By End-user
- Hospitals
- Cancer Research Institutes
- Diagnostic Laboratories
- Biopharmaceutical and Biotechnology Companies
- Others
By Region
North America
- U.S.
- Canada
Europe
- U.K.
- France
- Germany
- Italy
- Spain
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Singapore
- Rest of Asia Pacific
Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
Middle East & Africa
- GCC Countries
- South Africa
- Rest of Middle East & Africa
List of Companies:
- F. Hoffmann-La Roche Ltd.
- Thermo Fisher Scientific Inc.
- Illumina, Inc.
- QIAGEN N.V.
- Bio-Rad Laboratories, Inc.
- Abbott Laboratories
- Bristol Myers Squibb
- Agilent Technologies, Inc.
- Becton, Dickinson and Company (BD)
- Myriad Genetics, Inc.
- Sysmex Corporation
- Genomic Health
- PerkinElmer, Inc.
- Guardant Health, Inc.
- Foundation Medicine, Inc.
Maximize your value and knowledge with our 5 Reports-in-1 Bundle - over 40% off!
Our analysts are ready to help you immediately.